Zynex Inc. (ZYXI) News
Filter ZYXI News Items
ZYXI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ZYXI News Highlights
- For ZYXI, its 30 day story count is now at 2.
- Over the past 7 days, the trend for ZYXI's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
Latest ZYXI News From Around the Web
Below are the latest news stories about ZYNEX INC that investors may wish to consider to help them evaluate ZYXI as an investment opportunity.
Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov ForumThe post Full Video Coverage – Healthcare Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov Forum appeared first on CorpGov. |
12 Best Healthcare Stocks For the Long-TermIn this piece, we will take a look at the 12 best healthcare stocks for the long term. If you want to skip our overview of the healthcare industry, then you can take a look at 5 Best Healthcare Stocks For the Long-Term. The healthcare industry is one of the biggest industries in the world. […] |
Healthcare Edge: Trends, Financing, Future Directions in 2024 Panel at 3rd Palm Beach CorpGov ForumHealthcare Edge and Exec Edge are please to provide complete video coverage of the third annual Palm Beach CorpGov Forum, which was held on Nov. 8, featuring a full day of panels and fireside chats. The event was composed of over 200 attendees including public and private corporations, private equity and VC funds, institutions, family offices, attorneys, investment bankers, other […] |
Zynex Ranked in Forbes List of "America's Most Successful Small-Cap Companies 2024"Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked within Forbes' list of America's Most Successful Small-Cap Companies for 2024. The 2024 Forbes list of America's Most Successful Small-Cap Companies can be found at www.forbes.com. |
Zynex Submits FDA Application for its Next Generation NMES DeviceZynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for the M-Wave Neuromuscular Electrical Stimulation ("NMES") device. |
Zynex Named as a Winner in the Deloitte 2023 Technology Fast 500 Awards for the 5th Consecutive YearZynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced the Company has been ranked among all companies in the U.S. and Canada between 2019 and 2022 on Deloitte's Technology Fast 500. Zynex's revenues grew 248% over that period, with 2022 revenue reaching $158.2 million. The company estimates 2023 revenue between $189.5 and $194.5 mill |
Zynex (NASDAQ:ZYXI) shareholders have earned a 27% CAGR over the last five yearsWhen you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose... |
EXCLUSIVE: Medical Devices Firm Zynex Launches New $20M Share Repurchase ProgramZynex Inc's (NASDAQ: ZYXI) board of directors approved a program to repurchase up to $20.0 million. The program will commence on November 1, 2023, and is scheduled to terminate earlier than November 1, 2024, or when the $20.0 million limit is reached. Tuesday, Zynex initiated a process to evaluate potential strategic alternatives, confirming a Bloomberg report from Monday. It has retained Cantor Fitzgerald & Co. as its financial advisor. "Zynex recently announced strong earnings," said Thomas Sa |
Zynex Announces Share Repurchase ProgramZynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced that its board of directors approved a program to repurchase up to $20.0 million of the Company's common stock. The program will commence on November 1, 2023, and is scheduled to terminate on the earlier of November 1, 2024, or when the $20.0 million limit is reached. |
Zynex Announces Review of Strategic AlternativesZynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced its Board of Directors (the "Board") has initiated a process to evaluate potential strategic alternatives to maximize shareholder value. As part of the process, the Board will evaluate, together with its advisors, a range of potential strategic alternatives which may include, any |